Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans

Alzheimer's and Dementia

Volumn 11, Issue 7, 2015, Pages 792-814

  Saykin, Andrew J ^a,b   Shen, Li ^a,b   Yao, Xiaohui ^a,c   Kim, Sungeun ^a,b   Nho, Kwangsik ^a,b   Risacher, Shannon L ^a,b   Ramanan, Vijay K ^a,b   Foroud, Tatiana M ^b   Faber, Kelley M ^b   Sarwar, Nadeem ^d   Munsie, Leanne M ^e   Hu, Xiaolan ^f   Soares, Holly D ^f   Potkin, Steven G ^g   Thompson, Paul M ^h   Kauwe, John S K ⁱ   Kaddurah Daouk, Rima ^j   Green, Robert C ^k,l   Toga, Arthur W ^h   Weiner, Michael W ^m,n,o  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Indiana University   (United States)

^d EISAI CO LTD   (Japan)

^e ELI LILLY AND COMPANY   (United States)

^f BRISTOL MYERS SQUIBB   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ BRIGHAM YOUNG UNIVERSITY   (United States)

^j DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k LABORATORY FOR MOLECULAR MEDICINE   (United States)

^l BRIGHAM AND WOMEN S HOSPITAL   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

Alzheimer's disease (AD); Bioethical issues; Biomarkers; Cerebrospinal fluid (CSF); Cognition; Copy number variation (CNV); DNA; Genome wide association studies (GWAS); Magnetic resonance imaging (MRI); Memory; Mild cognitive impairment (MCI); Next generation sequencing (NGS); Positron emission tomography (PET); Precision medicine; RNA

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER; GENOMIC DNA; RNA; CARRIER PROTEIN; TOMM40 PROTEIN, HUMAN;

AGING; ALZHEIMER DISEASE; ARTICLE; BIOETHICS; BLOOD SAMPLING; CELL CYCLE; CEREBROSPINAL FLUID; COGNITION; COPY NUMBER VARIATION; DISEASE MARKER; EXOME; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN GENOME; LIPIDOMICS; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; MEMORY; METABOLOMICS; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEXT GENERATION SEQUENCING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHENOTYPE; PHENOTYPIC VARIATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; BIBLIOGRAPHIC DATABASE; COGNITIVE DEFECT; DISEASE COURSE; GENETIC ASSOCIATION STUDY; GENETICS; METABOLISM; STATISTICS AND NUMERICAL DATA;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; BIOMARKERS; COGNITIVE DYSFUNCTION; DATABASES, BIBLIOGRAPHIC; DISEASE PROGRESSION; GENETIC ASSOCIATION STUDIES; HUMANS; MEMBRANE TRANSPORT PROTEINS; NEUROIMAGING;

EID: 84937580795     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2015.05.009     Document Type: Review

References (175)

1. S.L. Risacher, S. Kim, K. Nho, T.M. Foroud, L. Shen, R.C. Petersen, and et al. APOE effect on Alzheimer's biomarkers in older adults with significant memory concern Alzheimers Dement 2015 http://dx.doi.org/10.1016/j.jalz.2015.03.003. [Epub ahead of print]
2. F. Jessen, R.E. Amariglio, M. van Boxtel, M. Breteler, M. Ceccaldi, G. Chetelat, and et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease Alzheimers Dement 10 2014 844 852
3. M.W. Weiner, D.P. Veitch, P.S. Aisen, L.A. Beckett, N.J. Cairns, R.C. Green, and et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Alzheimers Dement 9 2013 e111 e194
4. R.J. Bateman, P.S. Aisen, B. De Strooper, N.C. Fox, C.A. Lemere, J.M. Ringman, and et al. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease Alzheimers Res Ther 3 2011 1
5. J.C. Lambert, C.A. Ibrahim-Verbaas, D. Harold, A.C. Naj, R. Sims, C. Bellenguez, and et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease Nat Genet 45 2013 1452 1458
6. S.G. Potkin, J.A. Turner, G. Guffanti, A. Lakatos, F. Torri, D.B. Keator, and et al. Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations Cogn Neuropsychiatry 14 2009 391 418
7. S. Purcell, S.S. Cherny, and P.C. Sham Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits Bioinformatics 19 2003 149 150
8. A.J. Saykin, L. Shen, T.M. Foroud, S.G. Potkin, S. Swaminathan, S. Kim, and et al. Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: genetics core aims, progress, and plans Alzheimers Dement 6 2010 265 273
9. S.G. Potkin, G. Guffanti, A. Lakatos, J.A. Turner, F. Kruggel, J.H. Fallon, and et al. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease PLoS One 4 2009 e6501
10. L. Shen, P.M. Thompson, S.G. Potkin, L. Bertram, L.A. Farrer, T.M. Foroud, and et al. Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers Brain Imaging Behav 8 2014 183 207
11. P.W. Reymer, B.E. Groenemeyer, R. van de Burg, and J.J. Kastelein Apolipoprotein E genotyping on agarose gels Clin Chem 41 1995 1046 1047
12. J.E. Hixson, and D.T. Vernier Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI J Lipid Res 31 1990 545 548
13. J.R. Hawkins, Y. Khripin, A.M. Valdes, and T.A. Weaver Miniaturized sealed-tube allele-specific PCR Hum Mutat 19 2002 543 553
14. M.V. Myakishev, Y. Khripin, S. Hu, and D.H. Hamer High-throughput SNP genotyping by allele-specific PCR with universal energy-transfer-labeled primers Genome Res 11 2001 163 169
15. A.D. Roses An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease Arch Neurol 67 2010 536 541
16. K. Nho, J.J. Corneveaux, S. Kim, H. Lin, S.L. Risacher, L. Shen, and et al. Identification of functional variants from whole-exome sequencing, combined with neuroimaging genetics Mol Psychiatry 18 2013 739
17. K. Nho, J.J. Corneveaux, S. Kim, H. Lin, S.L. Risacher, L. Shen, and et al. Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment Mol Psychiatry 18 2013 781 787
18. R.A. Irizarry, B. Hobbs, F. Collin, Y.D. Beazer-Barclay, K.J. Antonellis, U. Scherf, and et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 4 2003 249 264
19. M.P. Vawter, S. Evans, P. Choudary, H. Tomita, J. Meador-Woodruff, M. Molnar, and et al. Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes Neuropsychopharmacology 29 2004 373 384
20. E.E. Schadt, S. Woo, and K. Hao Bayesian method to predict individual SNP genotypes from gene expression data Nat Genet 44 2012 603 608
21. E. Holmes, I.D. Wilson, and J.K. Nicholson Metabolic phenotyping in health and disease Cell 134 2008 714 717
22. R. Kaddurah-Daouk, and K.R. Krishnan Metabolomics: a global biochemical approach to the study of central nervous system diseases Neuropsychopharmacology 34 2009 173 186
23. R. Kaddurah-Daouk, and R.M. Weinshilboum Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology Clin Pharmacol Ther 95 2014 154 167
24. G.J. Patti, O. Yanes, and G. Siuzdak Innovation: metabolomics: the apogee of the omics trilogy Nat Rev Mol Cell Biol 13 2012 263 269
25. X. Han, S. Rozen, S.H. Boyle, C. Hellegers, H. Cheng, J.R. Burke, and et al. Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics PLoS One 6 2011 e21643
26. R. Kaddurah-Daouk, S. Rozen, W. Matson, X. Han, C.M. Hulette, J.R. Burke, and et al. Metabolomic changes in autopsy-confirmed Alzheimer's disease Alzheimers Dement: the journal of the Alzheimer's Association 7 2011 309 317
27. A.A. Motsinger-Reif, H. Zhu, M.A. Kling, W. Matson, S. Sharma, O. Fiehn, and et al. Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging Acta Neuropathol Commun 1 2013 28
28. S. Kim, S. Swaminathan, M. Inlow, S.L. Risacher, K. Nho, L. Shen, and et al. Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel PLoS One 8 2013 e70269
29. M. Boada, C. Antunez, R. Ramirez-Lorca, A.L. DeStefano, A. Gonzalez-Perez, J. Gayan, and et al. ATP5H/KCTD2 locus is associated with Alzheimer's disease risk Mol Psychiatry 19 2014 682 687
30. V. Leduc, L. De Beaumont, L. Theroux, D. Dea, P. Aisen, R.C. Petersen, and et al. HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study Mol Psychiatry 20 7 2014 867 873
31. A. Biffi, M.R. Sabuncu, R.S. Desikan, N. Schmansky, D.H. Salat, J. Rosand, and et al. Genetic variation of oxidative phosphorylation genes in stroke and Alzheimer's disease Neurobiol Aging 35 2014 1956 e1-8
32. J.H. Kim, P. Song, H. Lim, J.H. Lee, J.H. Lee, S.A. Park, and et al. Gene-based rare allele analysis identified a risk gene of Alzheimer's disease PLoS One 9 2014 e107983
33. R.S. Desikan, A.J. Schork, Y. Wang, A. Witoelar, M. Sharma, L.K. McEvoy, and et al. Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus Mol Psychiatry 2015 Feb 17
34. V.K. Ramanan, and A.J. Saykin Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders Am J Neurodegener Dis 2 2013 145 175
35. K. Nho, S. Kim, S.L. Risacher, L. Shen, J.J. Corneveaux, S. Swaminathan, and et al. Protective variant for hippocampal atrophy identified by whole exome sequencing Ann Neurol 77 2015 547 552
36. K. Nho, and A.J. Saykin Reply to letter to the editor Ann Neurol 2015 Apr 20
37. T. Lu, L. Aron, J. Zullo, Y. Pan, H. Kim, Y. Chen, and et al. REST and stress resistance in ageing and Alzheimer's disease Nature 507 2014 448 454
38. T.J. Hohman, M.E. Koran, T.A. Thornton-Wells Alzheimer's Disease Neuroimaging Initiative Genetic modification of the relationship between phosphorylated tau and neurodegeneration Alzheimers Dement: the journal of the Alzheimer's Association 10 2014 637 645.e1
39. T.J. Hohman, M.E. Koran, T.A. Thornton-Wells, and I. Alzheimer's Neuroimaging Genetic variation modifies risk for neurodegeneration based on biomarker status Front Aging Neurosci 6 2014 183
40. F.F. Roussotte, B.A. Gutman, D.P. Hibar, S.K. Madsen, K.L. Narr, P.M. Thompson, and et al. Carriers of a common variant in the dopamine transporter gene have greater dementia risk, cognitive decline, and faster ventricular expansion Alzheimers Dement: the journal of the Alzheimer's Association 2014 Dec 10
41. F.F. Roussotte, B.A. Gutman, S.K. Madsen, J.B. Colby, P.M. Thompson Alzheimer's Disease Neuroimaging Initiative Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly J Neurosci 34 2014 6537 6545
42. F.F. Roussotte, N. Jahanshad, D.P. Hibar, E.R. Sowell, O. Kohannim, M. Barysheva, and et al. A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations Hum Brain Mapp 35 2014 1226 1236
43. F.F. Roussotte, B.A. Gutman, D.P. Hibar, N. Jahanshad, S.K. Madsen, C.R. Jack Jr., and et al. A single nucleotide polymorphism associated with reduced alcohol intake in the RASGRF2 gene predicts larger cortical volumes but faster longitudinal ventricular expansion in the elderly Front Aging Neurosci 5 2013 93
44. E.O. Luis, S. Ortega-Cubero, I. Lamet, C. Razquin, C. Cruchaga, B.A. Benitez, and et al. Frontobasal gray matter loss is associated with the TREM2 p.R47H variant Neurobiol Aging 35 2014 2681 2690
45. P. Rajagopalan, D.P. Hibar, and P.M. Thompson TREM2 and neurodegenerative disease N Engl J Med 369 2013 1565 1567
46. M.E. Koran, T.J. Hohman, S.A. Meda, and T.A. Thornton-Wells Genetic interactions within inositol-related pathways are associated with longitudinal changes in ventricle size J Alzheimers Dis 38 2014 145 154
47. J.P. Andrawis, K.S. Hwang, A.E. Green, J. Kotlerman, D. Elashoff, J.H. Morra, and et al. Effects of ApoE4 and maternal history of dementia on hippocampal atrophy Neurobiol Aging 33 2012 856 866
48. L.G. Apostolova, K.S. Hwang, O. Kohannim, D. Avila, D. Elashoff, C.R. Jack Jr., and et al. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease Neuroimage Clin 4 2014 461 472
49. N. Jahanshad, P. Rajagopalan, X. Hua, D.P. Hibar, T.M. Nir, A.W. Toga, and et al. Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity Proc Natl Acad Sci U S A 110 2013 4768 4773
50. N.M. Warstadt, E.L. Dennis, N. Jahanshad, O. Kohannim, T.M. Nir, K.L. McMahon, and et al. Serum cholesterol and variant in cholesterol-related gene CETP predict white matter microstructure Neurobiol Aging 35 2014 2504 2513
51. Jahanshad N, Bhatt P, Hibar D.P, Villalon J.E, Nir T.M, Toga A.W, et al. Bivariate genome-wide association study of genetically correlated neuroimaging phenotypes from DTI and MRI through a seemingly unrelated regression model. MICCAI MBIA Workshop 2013. Nagoya, Japan 2013.
52. Jahanshad N, Kochunov P, Glahn D, Blangero J, Nichols T.E, McMahon K.L, et al. Power estimates for voxel-based genetic association studies using diffusion imaging. MICCAI MBIA Workshop 2013. Nagoya, Japan 2013. p. 12.
53. Warstadt N.M, Jahanshad N, Dennis E.L, Kohannim O, McMahon K.L, De Zubicaray G.I, et al. Identifying candidate gene effects by restricting search space in a multivariate genetic analysis of white matter microstructure. IEEE International Symposium on Biomedical Imaging. Beijing, China 2014.
54. S. Swaminathan, L. Shen, S.L. Risacher, K.K. Yoder, J.D. West, S. Kim, and et al. Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort Brain Imaging Behav 6 2012 1 15
55. E.M. Bradshaw, L.B. Chibnik, B.T. Keenan, L. Ottoboni, T. Raj, A. Tang, and et al. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology Nat Neurosci 16 2013 848 850
56. V.K. Ramanan, S.L. Risacher, K. Nho, S. Kim, S. Swaminathan, L. Shen, and et al. APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study Mol Psychiatry 19 2014 351 357
57. M. Thambisetty, Y. An, M. Nalls, J. Sojkova, S. Swaminathan, Y. Zhou, and et al. Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype Biol Psychiatry 73 2013 422 428
58. S. Swaminathan, S.L. Risacher, K.K. Yoder, J.D. West, L. Shen, S. Kim, and et al. Association of plasma and cortical amyloid beta is modulated by APOE epsilon4 status Alzheimers Dement 10 2014 e9 e18
59. K.R. Murphy, S.M. Landau, K.R. Choudhury, C.A. Hostage, K.S. Shpanskaya, H.I. Sair, and et al. Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth Neuroimage 78 2013 474 480
60. S.L. Risacher, S. Kim, L. Shen, K. Nho, T. Foroud, R.C. Green, and et al. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI) Front Aging Neurosci 5 2013 11
61. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, R.C. Petersen, M.W. Weiner, P.S. Aisen, and et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers Lancet Neurol 12 2013 207 216
62. J. Yan, L. Du, S. Kim, S.L. Risacher, H. Huang, J.H. Moore, and et al. Transcriptome-guided amyloid imaging genetic analysis via a novel structured sparse learning algorithm Bioinformatics 30 2014 i564 i571
63. T.J. Hohman, M.E. Koran, T.A. Thornton-Wells Alzheimer's Neuroimaging Initiative Interactions between GSK3beta and amyloid genes explain variance in amyloid burden Neurobiol Aging 35 2014 460 465
64. F. Schraml, K. Chen, N. Ayutyanont, R. Auttawut, J.B. Langbaum, W. Lee, and et al. Association between an Alzheimer's disease-related index and gene dose PLoS One 8 2013 e67163
65. K.R. Gray, P. Aljabar, R.A. Heckemann, A. Hammers, D. Rueckert Alzheimer's Disease Neuroimaging Initiative Random forest-based similarity measures for multi-modal classification of Alzheimer's disease Neuroimage 65 2013 167 175
66. J.L. Shaffer, J.R. Petrella, F.C. Sheldon, K.R. Choudhury, V.D. Calhoun, R. Edward Coleman, and et al. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers Radiology 266 2013 583 591
67. J.J. Gomar, C. Conejero-Goldberg, P. Davies, T.E. Goldberg Alzheimer's Disease Neuroimaging Initiative Extension and refinement of the predictive value of different classes of markers in ADNI: four-year follow-up data Alzheimers Dement 10 2014 704 712
68. C. Cruchaga, J.S. Kauwe, O. Harari, S.C. Jin, Y. Cai, C.M. Karch, and et al. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease Neuron 78 2013 256 268
69. V. Chouraki, R.F. De Bruijn, J. Chapuis, J.C. Bis, C. Reitz, S. Schraen, and et al. A genome-wide association meta-analysis of plasma Abeta peptides concentrations in the elderly Mol Psychiatry 19 2014 1326 1335
70. J.S. Kauwe, M.H. Bailey, P.G. Ridge, R. Perry, M.E. Wadsworth, K.L. Hoyt, and et al. Genome-wide association study of CSF levels of 59 Alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation PLoS Genet 10 2014 e1004758
71. A. Ramirez, W.M. van der Flier, C. Herold, D. Ramonet, S. Heilmann, P. Lewczuk, and et al. SUCLG2 identified as both a determinator of CSF Abeta1-42 levels and an attenuator of cognitive decline in Alzheimer's disease Hum Mol Genet 23 2014 6644 6658
72. J.B. Toledo, M. Bjerke, X. Da, S.M. Landau, N.L. Foster, W. Jagust, and et al. Nonlinear association between cerebrospinal fluid and florbetapir F-18 beta-amyloid measures across the spectrum of Alzheimer disease JAMA Neurol 72 2015 571 581
73. Y.L. Chang, C. Fennema-Notestine, D. Holland, L.K. McEvoy, N.H. Stricker, D.P. Salmon, and et al. APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's disease Alzheimers Dement 10 2014 336 348
74. P.L. De Jager, J.M. Shulman, L.B. Chibnik, B.T. Keenan, T. Raj, R.S. Wilson, and et al. A genome-wide scan for common variants affecting the rate of age-related cognitive decline Neurobiol Aging 33 2012 1017 e1-15
75. M.C. Donohue, R.A. Sperling, D.P. Salmon, D.M. Rentz, R. Raman, R.G. Thomas, and et al. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline JAMA Neurol 71 2014 961 970
76. E.C. Mormino, R.A. Betensky, T. Hedden, A.P. Schultz, A. Ward, W. Huijbers, and et al. Amyloid and APOE epsilon4 interact to influence short-term decline in preclinical Alzheimer disease Neurology 82 2014 1760 1767
77. K. Kantarci, V. Lowe, S.A. Przybelski, S.D. Weigand, M.L. Senjem, R.J. Ivnik, and et al. APOE modifies the association between Abeta load and cognition in cognitively normal older adults Neurology 78 2012 232 240
78. S. Barral, T. Bird, A. Goate, M.R. Farlow, R. Diaz-Arrastia, D.A. Bennett, and et al. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory Neurology 78 2012 1464 1471
79. R. Sherva, Y. Tripodis, D.A. Bennett, L.B. Chibnik, P.K. Crane, P.L. de Jager, and et al. Genome-wide association study of the rate of cognitive decline in Alzheimer's disease Alzheimers Dement 10 2014 45 52
80. V.K. Ramanan, K. Nho, L. Shen, S.L. Risacher, S. Kim, B.C. McDonald, and et al. FASTKD2 is associated with memory and hippocampal structure in older adults Mol Psychiatry 16 5 2014 429 432
81. V.K. Ramanan, and A.J. Saykin FASTKD2 and human memory: functional pathways and prospects for novel therapeutic target development for Alzheimer's disease and age-associated memory decline Pharmacogenomics 16 2015 429 432
82. D.P. Hibar, J.L. Stein, M.E. Renteria, A. Arias-Vasquez, S. Desrivieres, N. Jahanshad, and et al. Common genetic variants influence human subcortical brain structures Nature 520 2015 224 229
83. T.E. Bakken, J.C. Roddey, S. Djurovic, N. Akshoomoff, D.G. Amaral, C.S. Bloss, and et al. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans Proc Natl Acad Sci U S A 109 2012 3985 3990
84. J.L. Stein, X. Hua, S. Lee, A.J. Ho, A.D. Leow, A.W. Toga, and et al. Voxelwise genome-wide association study (vGWAS) Neuroimage 53 2010 1160 1174
85. B.A. Benitez, C.M. Karch, Y. Cai, S.C. Jin, B. Cooper, D. Carrell, and et al. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-epsilon4 carriers PLoS Genet 9 2013 e1003685
86. V.K. Ramanan, S. Kim, K. Holohan, L. Shen, K. Nho, S.L. Risacher, and et al. Genome-wide pathway analysis of memory impairment in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks Brain Imaging Behav 6 2012 634 648
87. S. Mukherjee, S. Kim, V.K. Ramanan, L.E. Gibbons, K. Nho, M.M. Glymour, and et al. Gene-based GWAS and biological pathway analysis of the resilience of executive functioning Brain Imaging Behav 8 2014 110 118
88. K. Nho, V.K. Ramanan, E. Horgusluoglu, S. Kim, M.H. Inlow, S.L. Risacher, and et al. Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults J Alzheimers Dis 45 2015 1197 1206
89. V.K. Ramanan, L. Shen, J.H. Moore, and A.J. Saykin Pathway analysis of genomic data: concepts, methods, and prospects for future development Trends Genet 28 2012 323 332
90. S.E. Harris, and I.J. Deary The genetics of cognitive ability and cognitive ageing in healthy older people Trends Cogn Sci 15 2011 388 394
91. A. Papassotiropoulos, and D.J. de Quervain Genetics of human episodic memory: dealing with complexity Trends Cogn Sci 15 2011 381 387
92. C.A. Rietveld, S.E. Medland, J. Derringer, J. Yang, T. Esko, N.W. Martin, and et al. GWAS of 126,559 individuals identifies genetic variants associated with educational attainment Science 340 2013 1467 1471
93. R.J. Caselli, A.C. Dueck, D. Osborne, M.N. Sabbagh, D.J. Connor, G.L. Ahern, and et al. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect N Engl J Med 361 2009 255 263
94. O.J. Schiepers, S.E. Harris, A.J. Gow, A. Pattie, C.E. Brett, J.M. Starr, and et al. APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921 Mol Psychiatry 17 2012 315 324
95. D. Holland, L.K. McEvoy, R.S. Desikan, and A.M. Dale Enrichment and stratification for predementia Alzheimer disease clinical trials PLoS One 7 2012 e47739
96. M.F. Egan, M. Kojima, J.H. Callicott, T.E. Goldberg, B.S. Kolachana, A. Bertolino, and et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function Cell 112 2003 257 269
97. R.A. Honea, C. Cruchaga, R.D. Perea, A.J. Saykin, J.M. Burns, D.R. Weinberger, and et al. Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration PLoS One 8 2013 e76001
98. Y.Y. Lim, V.L. Villemagne, S.M. Laws, R.H. Pietrzak, P.J. Snyder, D. Ames, and et al. APOE and BDNF polymorphisms moderate amyloid beta-related cognitive decline in preclinical Alzheimer's disease Mol Psychiatry 2014 Oct 7
99. J.J. Corneveaux, W.S. Liang, E.M. Reiman, J.A. Webster, A.J. Myers, V.L. Zismann, and et al. Evidence for an association between KIBRA and late-onset Alzheimer's disease Neurobiol Aging 31 2010 901 909
100. A. Milnik, A. Heck, C. Vogler, H.J. Heinze, D.J. de Quervain, and A. Papassotiropoulos Association of KIBRA with episodic and working memory: a meta-analysis Am J Med Genet B Neuropsychiatr Genet 159B 2012 958 969
101. A.C. Need, D.K. Attix, J.M. McEvoy, E.T. Cirulli, K.N. Linney, A.P. Wagoner, and et al. Failure to replicate effect of Kibra on human memory in two large cohorts of European origin Am J Med Genet B Neuropsychiatr Genet 147B 2008 667 668
102. A. Papassotiropoulos, D.A. Stephan, M.J. Huentelman, F.J. Hoerndli, D.W. Craig, J.V. Pearson, and et al. Common Kibra alleles are associated with human memory performance Science 314 2006 475 478
103. M.D. Ritchie, E.R. Holzinger, R. Li, S.A. Pendergrass, and D. Kim Methods of integrating data to uncover genotype-phenotype interactions Nat Rev Genet 16 2015 85 97
104. P.T. Trzepacz, P. Yu, J. Sun, K. Schuh, M. Case, M.M. Witte, and et al. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia Neurobiol Aging 35 2014 143 151
105. Z. Zhang, H. Huang, D. Shen Alzheimer's Disease Neuroimaging Initiative Integrative analysis of multi-dimensional imaging genomics data for Alzheimer's disease prediction Front Aging Neurosci 6 2014 260
106. K. Bettens, K. Sleegers, and C. Van Broeckhoven Genetic insights in Alzheimer's disease Lancet Neurol 12 2013 92 104
107. G.W. Beadle, and E.L. Tatum Genetic control of biochemical reactions in neurospora Proc Natl Acad Sci U S A 27 1941 499 506
108. M. Vidal, M.E. Cusick, and A.L. Barabasi Interactome networks and human disease Cell 144 2011 986 998
109. M. Ala-Korpela, A.J. Kangas, and M. Inouye Genome-wide association studies and systems biology: together at last Trends Genet 27 2011 493 498
110. A. Califano, A.J. Butte, S. Friend, T. Ideker, and E. Schadt Leveraging models of cell regulation and GWAS data in integrative network-based association studies Nat Genet 44 2012 841 847
111. L. Hood Systems biology and p4 medicine: past, present, and future Rambam Maimonides Med J 4 2013 e0012
112. A.L. Barabasi, N. Gulbahce, and J. Loscalzo Network medicine: a network-based approach to human disease Nat Rev Genet 12 2011 56 68
113. P. Hollingworth, D. Harold, R. Sims, A. Gerrish, J.C. Lambert, M.M. Carrasquillo, and et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease Nat Genet 43 2011 429 435
114. A.C. Naj, G. Jun, G.W. Beecham, L.S. Wang, B.N. Vardarajan, J. Buros, and et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease Nat Genet 43 2011 436 441
115. D.G. Walker, A.M. Whetzel, G. Serrano, L.I. Sue, T.G. Beach, and L.F. Lue Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex Neurobiol Aging 36 2015 571 582
116. M. Malik, J. Chiles 3rd, H.S. Xi, C. Medway, J. Simpson, S. Potluri, and et al. Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia Hum Mol Genet 24 2015 3557 3570
117. O. Zuk, S.F. Schaffner, K. Samocha, R. Do, E. Hechter, S. Kathiresan, and et al. Searching for missing heritability: designing rare variant association studies Proc Natl Acad Sci U S A 111 2014 E455 E464
118. H. Rhinn, R. Fujita, L. Qiang, R. Cheng, J.H. Lee, and A. Abeliovich Integrative genomics identifies APOE epsilon4 effectors in Alzheimer's disease Nature 500 2013 45 50
119. B. Zhang, C. Gaiteri, L.G. Bodea, Z. Wang, J. McElwee, A.A. Podtelezhnikov, and et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease Cell 153 2013 707 720
120. N.M. Penrod, R. Cowper-Sal-lari, and J.H. Moore Systems genetics for drug target discovery Trends Pharmacol Sci 32 2011 623 630
121. A.C. Janssens, and C.M. van Duijn Genome-based prediction of common diseases: advances and prospects Hum Mol Genet 17 2008 R166 R173
122. M. Fan, B. Liu, Y. Zhou, X. Zhen, C. Xu, T. Jiang, and et al. Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults Neurosci Lett 479 2010 332 336
123. A.C. Naj, G. Jun, C. Reitz, B.W. Kunkle, W. Perry, Y.S. Park, and et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study JAMA Neurol 71 2014 1394 1404
124. R.S. Doody, R.G. Thomas, M. Farlow, T. Iwatsubo, B. Vellas, S. Joffe, and et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease N Engl J Med 370 2014 311 321
125. S. Salloway, R. Sperling, N.C. Fox, K. Blennow, W. Klunk, M. Raskind, and et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease N Engl J Med 370 2014 322 333
126. M.R. Sabuncu, R.L. Buckner, J.W. Smoller, P.H. Lee, B. Fischl, R.A. Sperling, and et al. The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects Cereb Cortex 22 2012 2653 2661
127. E. Rodriguez-Rodriguez, P. Sanchez-Juan, J.L. Vazquez-Higuera, I. Mateo, A. Pozueta, J. Berciano, and et al. Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease J Neural Transm 120 2013 807 812
128. L.A. Garraway Genomics-driven oncology: framework for an emerging paradigm J Clin Oncol 31 2013 1806 1814
129. E.M. Van Allen, N. Wagle, and M.A. Levy Clinical analysis and interpretation of cancer genome data J Clin Oncol 31 2013 1825 1833
130. D. Cook, D. Brown, R. Alexander, R. March, P. Morgan, G. Satterthwaite, and et al. Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework Nat Rev Drug Discov 13 2014 419 431
131. R.M. Plenge, E.M. Scolnick, and D. Altshuler Validating therapeutic targets through human genetics Nat Rev Drug Discov 12 2013 581 594
132. S. Burgess, A. Butterworth, A. Malarstig, and S.G. Thompson Use of Mendelian randomisation to assess potential benefit of clinical intervention BMJ 345 2012 e7325
133. International Genomics of Alzheimer's Disease Consortium Convergent genetic and expression data implicate immunity in Alzheimer's disease Alzheimers Dement 11 2015 658 671
134. M.T. Heneka, D.T. Golenbock, and E. Latz Innate immunity in Alzheimer's disease Nat Immunol 16 2015 229 236
135. R. Guerreiro, A. Wojtas, J. Bras, M. Carrasquillo, E. Rogaeva, E. Majounie, and et al. TREM2 variants in Alzheimer's disease N Engl J Med 368 2013 117 127
136. J. Yu, and J.A. Thomson Pluripotent stem cell lines Genes Dev 22 2008 1987 1997
137. T. Yagi, D. Ito, Y. Okada, W. Akamatsu, Y. Nihei, T. Yoshizaki, and et al. Modeling familial Alzheimer's disease with induced pluripotent stem cells Hum Mol Genet 20 2011 4530 4539
138. M.A. Israel, S.H. Yuan, C. Bardy, S.M. Reyna, Y. Mu, C. Herrera, and et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells Nature 482 2012 216 220
139. R. Barrett, L. Ornelas, N. Yeager, B. Mandefro, A. Sahabian, L. Lenaeus, and et al. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines Stem Cells Transl Med 3 2014 1429 1434
140. J.E. Young, J. Boulanger-Weill, D.A. Williams, G. Woodruff, F. Buen, A.C. Revilla, and et al. Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells Cell Stem Cell 16 2015 373 385
141. S.H. Choi, Y.H. Kim, M. Hebisch, C. Sliwinski, S. Lee, C. D'Avanzo, and et al. A three-dimensional human neural cell culture model of Alzheimer's disease Nature 515 2014 274 278
142. S.M. Wolf, F.P. Lawrenz, C.A. Nelson, J.P. Kahn, M.K. Cho, E.W. Clayton, and et al. Managing incidental findings in human subjects research: analysis and recommendations J Law Med Ethics 36 2008 219-248, 211
143. C. Weiner Anticipate and communicate: ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts (December 2013 report of the Presidential Commission for the Study of Bioethical Issues) Am J Epidemiol 180 2014 562 564
144. R. Morello-Frosch, J. Varshavsky, M. Liboiron, P. Brown, and J.G. Brody Communicating results in post-Belmont era biomonitoring studies: lessons from genetics and neuroimaging research Environ Res 136 2015 363 372
145. T.C. Booth, A. Jackson, J.M. Wardlaw, S.A. Taylor, and A.D. Waldman Incidental findings found in "healthy" volunteers during imaging performed for research: current legal and ethical implications Br J Radiol 83 2010 456 465
146. J.M. Shoemaker, M.T. Holdsworth, C. Aine, V.D. Calhoun, R. de La Garza, S.W. Feldstein Ewing, and et al. A practical approach to incidental findings in neuroimaging research Neurology 77 2011 2123 2127
147. T.C. Booth, A.D. Waldman, J.M. Wardlaw, S.A. Taylor, and A. Jackson Management of incidental findings during imaging research in "healthy" volunteers: current UK practice Br J Radiol 85 2012 11 21
148. G.P. Jarvik, L.M. Amendola, J.S. Berg, K. Brothers, E.W. Clayton, W. Chung, and et al. Return of genomic results to research participants: the floor, the ceiling, and the choices in between Am J Hum Genet 94 2014 818 826
149. J.S. Berg, L.M. Amendola, C. Eng, E. Van Allen, S.W. Gray, N. Wagle, and et al. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium Genet Med 15 2013 860 867
150. S.M. Wolf, B.N. Crock, B. Van Ness, F. Lawrenz, J.P. Kahn, L.M. Beskow, and et al. Managing incidental findings and research results in genomic research involving biobanks and archived datasets Genet Med 14 2012 361 384
151. J. Suhr, and J. Gunstad 'Diagnosis threat': the effect of negative expectations on cognitive performance in head injury J Clin Exp Neuropsychol 24 2002 448 457
152. T. Lineweaver, M. Bondi, D. Galasko, and D. Salmon Knowledge of APOE genotype affects subjective and objective memory performance in healthy older adults Am J Psychiatry 171 2013 201 208
153. D.I. Shalowitz, and F.G. Miller Communicating the results of clinical research to participants: attitudes, practices, and future directions PLoS Med 5 2008 e91
154. P. Neumann, J. Cohen, and J. Hammitt Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents Health Econ 21 2012 238 251
155. E. Wikler, R. Blendon, and J. Benson Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease Alzheimers Res Ther 5 2013 43
156. E.P. Klein, and J. Kaye Dementia specialists and early adoption of amyloid imaging J Alzheimers Dis 33 2013 445 450
157. K. Johnson, S. Minoshima, N. Bohnen, K. Donohoe, N. Foster, P. Herscovitch, and et al. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association J Nucl Med 54 2013 14
158. K. Johnson, S. Minoshima, N. Bohnen, K. Donohoe, N. Foster, P. Herscovitch, and et al. Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment and education Alzheimers Dement 9 2013 e106 e109
159. National Coverage Analysis. Proposed decision memo for beta amyloid positron emission tomography in dementia and neurodegenerative disease (CAG-00431N). Centers for Medicare and Medicaid Services (CMS). Available at: http://www.cms.gov/medicare-coverage-database/details/nca-proposed-decision-memo.aspx?NCAId=265. Accessed June 25, 2015.
160. M.B. Rogers Coverage denial for amyloid scans riles Alzheimer's community AlzForum 2013 Available at: http://www.alzforum.org/news/conference-coverage/coverage-denial-amyloid-scans-riles-alzheimers-community. Accessed June 25, 2015
161. M. Shulman, K. Harkins, R.C. Green, and J. Karlawish Using AD biomarker research results for clinical care: a survey of ADNI investigators Neurology 81 2013 1114 1121
162. L.G. Dressler, S. Smolek, R. Ponsaran, J.M. Markey, H. Starks, N. Gerson, and et al. IRB perspectives on the return of individual results from genomic research Genet Med 14 2012 215 222
163. W. Burke, B.J. Evans, and G.P. Jarvik Return of results: ethical and legal distinctions between research and clinical care Am J Med Genet C Semin Med Genet 166C 2014 105 111
164. R.R. Fabsitz, A. McGuire, R.R. Sharp, M. Puggal, L.M. Beskow, L.G. Biesecker, and et al. Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group Circ Cardiovasc Genet 3 2010 574 580
165. L.G. Biesecker, and R.C. Green Diagnostic clinical genome and exome sequencing N Engl J Med 370 2014 2418 2425
166. Y. Yang, D.M. Muzny, F. Xia, Z. Niu, R. Person, Y. Ding, and et al. Molecular findings among patients referred for clinical whole-exome sequencing JAMA 312 2014 1870 1879
167. R.C. Green, J.S. Berg, W.W. Grody, S.S. Kalia, B.R. Korf, C.L. Martin, and et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing Genet Med 15 2013 565 574
168. ACMG Board of Directors ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing Genet Med 17 2015 68 69
169. R.C. Green, J. Lupski, and L.G. Biesecker Reporting genomic sequencing results to ordering clinicians: incidental, but not exceptional JAMA 310 2013 365 366
170. S.M. Wolf, R. Branum, B.A. Koenig, G.M. Petersen, S.A. Berry, L.M. Beskow, and et al. Returning a research participant's genomic results to relatives: analysis and recommendations J Law Med Ethics 2015 In press
171. R.C. Green, J.S. Roberts, L.A. Cupples, N.R. Relkin, P.J. Whitehouse, T. Brown, and et al. Disclosure of APOE genotype for risk of Alzheimer's disease N Engl J Med 361 2009 245 254
172. J. Roberts, K. Christensen, and R.C. Green Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics Clin Genet 80 2011 407 414
173. D.M. Lautenbach, K.D. Christensen, J.A. Sparks, and R.C. Green Communicating genetic risk information for non-Mendelian variants Annu Rev Genomomics Hum Genet 14 2013 491 513
174. R.C. Green, K.D. Christensen, L.A. Cupples, N.R. Relkin, P.J. Whitehouse, C.D. Royal, and et al. A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease Alzheimers Dement 2014 Dec 9
175. M. Gymrek, A. McGuire, D. Golan, E. Halperin, and Y. Erlich Identifying personal genomes by surname inference Science 339 2012 321 324